cas 2641216-67-1|| where to buy 19-chloro-22-[2,5-dimethyl-4-(prop-2-enoyl)piperazin-1-yl]-13,16-difluoro-3-(propan-2-yl)-8,11-dioxa-1,4,23,26-tetraazapentacyclo[16.6.2.0²,⁷.0¹²,¹⁷.0²¹,²⁵]hexacosa-2(7),3,5,12,14,16,18,20,22,25-decaen-24-one

Nombre del producto:19-chloro-22-[2,5-dimethyl-4-(prop-2-enoyl)piperazin-1-yl]-13,16-difluoro-3-(propan-2-yl)-8,11-dioxa-1,4,23,26-tetraazapentacyclo[16.6.2.0²,⁷.0¹²,¹⁷.0²¹,²⁵]hexacosa-2(7),3,5,12,14,16,18,20,22,25-decaen-24-one

IUPAC Name:19-chloro-22-[2,5-dimethyl-4-(prop-2-enoyl)piperazin-1-yl]-13,16-difluoro-3-(propan-2-yl)-8,11-dioxa-1,4,23,26-tetraazapentacyclo[16.6.2.0²,⁷.0¹²,¹⁷.0²¹,²⁵]hexacosa-2(7),3,5,12,14,16,18,20,22,25-decaen-24-one

: CAS：2641216-67-1; Fórmula molecular：C32H31ClF2N6O4; Pureza：95%+

: Número de catálogo：CM1078967; Peso molecular：637.08

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Consulta: sales@chemenu.com

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2641216-67-1 regularly via the above email.

Notas adicionales

Verification code*

refresh

Detalles del producto

: Núm. De CAS :2641216-67-1; Fórmula molecular:C32H31ClF2N6O4; Punto de fusión:-; Código de sonrisas:CC1CN(C(CN1C(=O)C=C)C)C2=NC(=O)N3C4=C(C=CN=C4C(C)C)OCCOC5=C(C=CC(=C5C6=C(C=C2C3=N6)Cl)F)F; Densidad:

: Número de catálogo:CM1078967; Peso molecular:637.08; Punto de ebullición:; Nº Mdl:; Almacenamiento:

Category Infos

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.